Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Amylin and J&J expand product development program

June 25, 1997

Update on clinical progression of Amylin's diabetes drug

June 25, 1997

DuPont Merck seeks to license cholesterol-lowering agent

June 25, 1997

Hypocholesterolemic compounds reported by Schering-Plough

June 23, 1997

Promising results reported for Senetek's INVICORP for male erectile dysfunction

June 19, 1997

Novartis and Osiris Therapeutics to codevelop bone and cartilage disease therapies

June 18, 1997

First clinical trials results reported for leptin

June 18, 1997

Zonagen reports results of second phase III trial of Vasomax

June 17, 1997

New vial size of generic leucovorin approved by FDA

June 17, 1997

Vitamin E for maternal diabetes-associated malformations in offspring

June 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...